Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001341004-08-002902
Filing Date
2008-11-18
Accepted
2008-11-18 10:30:59
Documents
1
Group Members
ENSO CAPITAL MANAGEMENT, LTD.ENSO GLOBAL EQUITIES LEVERED MASTER PARTNERSHIP, LPENSO GLOBAL EQUITIES MASTER PARTNERSHIP, LPJOSHUA A. FINK

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A ensocapital-llc_13da.htm SC 13D/A 197083
  Complete submission text file 0001341004-08-002902.txt   199179
Mailing Address 3960 BROADWAY NEW YORK NY 10032
Business Address 3960 BROADWAY NEW YORK NY 10032 2127815113
NEPHROS INC (Subject) CIK: 0001196298 (see all company filings)

EIN.: 133971809 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-80319 | Film No.: 081197207
SIC: 3841 Surgical & Medical Instruments & Apparatus

Mailing Address 540 MADISON AVENUE SUITE 18A NEW YORK CITY NY 10022
Business Address 540 MADISON AVENUE SUITE 18A NEW YORK CITY NY 10022 212-829-3500
Enso Capital Management LLC (Filed by) CIK: 0001351462 (see all company filings)

EIN.: 412025458 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A